Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US0153511094
Ticker ALXN
Company ALEXION PHARMACEUTICALS
Currency $
Price
Aware Investor Index (AII) 0.0006
Recommendation STRONG SELL
P/E 85.15
ROE 3.05 %
Capitalization 23,814,960,000 $
Dividend Yield 0.00 %
P/S 5.76
AII Position 683
P/E Position 684
ROE Position 680
Capitalization Position 326
Dividend Yield Position 597
Sales 4,131,200,000 $
10-Year Average Earnings 279,682,500 $
Shares Outstanding 224,500,000
Equity 9,165,300,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
ALEXION PHARMACEUTICALS Investor Relations Web Site http://ir.alexion.com/







Sales:

YEAR MONTH AMOUNT
2018 12 4,131,200,000.00 $
2017 12 3,551,100,000.00 $
2016 12 3,084,100,000.00 $
2015 12 2,604,047,000.00 $
2014 12 2,233,733,000.00 $
2013 12 1,551,346,000.00 $
2012 12 1,134,114,000.00 $
2011 12 783,431,000.00 $
2010 12 540,957,000.00 $
2009 12 386,800,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 77,600,000.00 $
2017 12 443,300,000.00 $
2016 12 399,400,000.00 $
2015 12 144,385,000.00 $
2014 12 656,912,000.00 $
2013 12 252,895,000.00 $
2012 12 254,822,000.00 $
2011 12 175,315,000.00 $
2010 12 97,030,000.00 $
2009 12 295,166,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 9,165,300,000.00 $
2017 12 8,893,100,000.00 $
2016 12 8,693,800,000.00 $
2015 12 8,258,616,000.00 $
2014 12 3,302,018,000.00 $
2013 12 2,382,079,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 224,500,000
2017 12 225,400,000
2016 12 226,300,000
2015 12 215,933,000
2014 12 201,623,000
2013 12 199,712,000

 












Bloomberg News for ALEXION PHARMACEUTICALS:



Google News for ALEXION PHARMACEUTICALS:

WCX19 - 8 hours ago
Alexion Pharmaceuticals, Inc. ($ALXN) Is Moving – Here's Why ...
On its latest session, Alexion Pharmaceuticals, Inc. ($ALXN) opened at 107.28, reaching a high of 111.04 and a low of 107.0 before closing at a ...
Casper Courier - 7 hours ago
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Shares Acquired by ...
Synovus Financial Corp lifted its position in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 4.6% in the third quarter, according to ...
Darby News
First Week of December 20th Options Trading For Alexion ...
... 20th Options Trading For Alexion Pharmaceuticals (ALXN) ... If an investor was to purchase shares of ALXN stock at the current price level of ...
Mitchell Messenger
Alexion Pharmaceuticals (ALXN) Q3 Earnings and Revenues Top ...
Alexion, which belongs to the Zacks Medical - Biomedical and Genetics ... Alexion Pharmaceuticals, Inc. (ALXN): Free Stock Analysis Report
Slater Sentinel
Alexion Pharmaceuticals' (ALXN) Buy Rating Reaffirmed at Cowen
Cowen reiterated their buy rating on shares of Alexion Pharmaceuticals (NASDAQ:ALXN) in a report issued on Wednesday, October 16th, ...
Nasdaq - 22 Oct 2019
Alexion Pharmaceuticals, Inc. [ALXN] Holding Strong: What's ...
Alexion Pharmaceuticals, Inc. [ALXN] saw a change by -1.20% with the Thursday trading session, closing the trade at the price of $107.23.
Nasdaq - 23 Oct 2019
A Lot Stronger Than You Think? – Alexion Pharmaceuticals, Inc ...
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has its shares plummet by -21.9% or $31.07 from its all-time high of $141.86, with ALXN ...
Mitchell Messenger - 1 day ago
Toronto Dominion Bank Upped Its Alexion Pharmaceuticals (ALXN ...
Toronto Dominion Bank increased Alexion Pharmaceuticals Inc (ALXN) stake by 2.24% reported in 2019Q2 SEC filing. Toronto Dominion Bank ...
US Post News
Is It Time For A Financial Check:: Alexion Pharmaceuticals, Inc ...
On Monday, November 04, 2019, the Company, Alexion Pharmaceuticals, Inc., ALXN stock construct a change of -0.78 percent (↓ / Loss) in a ...
Times Of New York
Alexion Pharmaceuticals (ALXN) to reach at $153.85 in coming one ...
Alexion Pharmaceuticals (ALXN). The stock price value Change from Open was at 5.57% with a Gap of 1.73%. The Average True Range was ...


Back